DanielHAhnDOM.S.
Oncology • Scottsdale, AZGastrointestinal Cancer, Hematologic Oncology
Senior Associate Consultant, Assistant Professor
Dr. Ahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
Ohio State UniversityM.S., Clinical Investigation, 2014 - 2016
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2009 - 2011
Texas College of Osteopathic MedicineClass of 2008
Certifications & Licensure
AZ State License 2016 - 2027
TX State License 2011 - 2026
OH State License 2013 - 2017
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- ASCO GI Symposium Merit Award ASCO, 2016
- ASCO/CCF Young Investigator Award ASCO, 2015
Clinical Trials
- TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2017 Dec 11
- A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma Start of enrollment: 2018 Mar 07
- Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
- Join now to see all
Publications & Presentations
PubMed
- Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy.Cody Eslinger, Daniel Walden, Alyssa McGary, Oluwadunni Emiloju, Daniel Ahn
Cancer. 2025-02-15 - Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer.Oluseyi Abidoye, Daniel H Ahn, Mitesh J Borad, Christina Wu, Tanios Bekaii-Saab
Cells. 2025-01-22 - Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study.Farshid Dayyani, Heide A Stirnadel-Farrant, Jenny Hu, Yian Lin, Nehemiah Kebede
Cancers. 2025-01-18
Journal Articles
- Systemic Therapy and Sequencing Options in Advanced Hepatocellular CarcinomaMohamad Bassam Sonbol, Amit Mahipal, Zhaohui Jin, Kabir Mody, Mitesh J Borad, Daniel H Ahn, Tanios Bekaii-Saab, JAMA Oncology
- Targeting the Stroma in Pancreatic CancerDaniel H Ahn, Ramesh K Ramanathan, Annals of Palliative Medicine
Press Mentions
Neoadjuvant Chemotherapy Regimen Extends Survival in Pancreatic CancerJuly 14th, 2022- Cardiff Oncology Announces First Patient Dosed in a Phase 2 Trial of Onvansertib in Combination with Irinotecan and 5-FU in Pancreatic CancerJune 8th, 2021
- Why Cardiff Oncology Stock Is Crashing TodayJanuary 15th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
